Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.

ABSTRACT:

SUBMITTER: Rodler E 

PROVIDER: S-EPMC9924094 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature